CARLSBAD, Calif.–(BUSINESS WIRE)–Ra Medical Systems, manufacturers of laser-based solutions for the treatment of cardiovascular and dermatological diseases, announced today that the Company has appointed Andrew Jackson as its Chief Financial Officer, effective immediately. Mr. Jackson has over 20 years of finance experience in life science and technology companies, including extensive […]
Financial
Penumbra, Inc. Schedules First Quarter 2018 Earnings Release and Conference Call for May 8, 2018
ALAMEDA, Calif., April 18, 2018 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2018 after market close on Tuesday, May 8, 2018 at 4:30 PM Eastern Time. A press release with first quarter 2018 financial results will be issued after market […]
CryoLife Announces Release Date and Teleconference Call Details for 2018 First Quarter Financial Results
ATLANTA, April 17, 2018 /PRNewswire/ — CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2018 first quarter financial results will be released on Wednesday, May 2, 2018 after the market closes. On Thursday, May 3, 2018 the Company will hold a teleconference call and live webcast at 8:00 […]
Abbott Reports First-Quarter 2018 Results
ABBOTT PARK, Ill., April 18, 2018 /PRNewswire/ — Abbott (NYSE: ABT) today announced financial results for the first quarter ended March 31, 2018. First-quarter worldwide sales of $7.4 billion increased 16.7 percent on a reported basis and 6.9 percent on an organic* basis. Reported diluted EPS from continuing operations under GAAP was $0.23 in the first quarter. Adjusted diluted EPS from […]
LimFlow Raises €27 Million ($33.5 Million) in Series C Financing Led by Sofinnova Partners to Advance Innovative Critical Limb Ischemia (CLI) Treatment
PARIS–(BUSINESS WIRE)–LimFlow SA, developer of innovative, peripheral endovascular technology transforming the treatment of critical limb ischemia (CLI), today announced it has secured €27 million ($33.5 million) in an oversubscribed Series C financing. The round was led by Sofinnova Partners, with continued participation from existing round B investors Bpifrance, the French […]
Abiomed Fourth Quarter Fiscal 2018 Earnings and Conference Call Notification
DANVERS, Mass., April 13, 2018 (GLOBE NEWSWIRE) — Abiomed, Inc. (NASDAQ:ABMD) announced that on Thursday, May 3, 2018, the Company will release financial results for the fourth quarter of fiscal 2018. The Company will host a conference call to discuss the results on Thursday, May 3, 2018, at 8:00 a.m. EDT. […]
Cardiovascular Systems, Inc. to Webcast Fiscal 2018 Third-Quarter Earnings Conference Call Wednesday, May 2
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII) will host a live webcast of its fiscal 2018 third-quarter conference call on Wednesday, May 2, 2018, at 3:45 p.m. CT (4:45 p.m. ET). CSI management will discuss results for its fiscal third quarter ended March 31, 2018, and its financial […]
Merit Medical Systems to Announce First Quarter Results on April 25, 2018
SOUTH JORDAN, Utah, April 11, 2018 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy, announced today that it will release its financial results for the […]
SecurAcath Selected for Fast-Track NHS Use Through New Innovation and Technology Payment Program
PLYMOUTH, Minn.–(BUSINESS WIRE)–Interrad Medical, a privately held medical device company, announces the SecurAcath Subcutaneous Catheter Securement Device has been selected for the Innovation and Technology Payment (ITP) Program by the National Health Service (NHS) England. The ITP Program is designed to remove significant barriers to the spread and adoption of […]
Global Interventional Cardiology and Peripheral Vascular Device Market 2018-2023 – A $26.3 Billion Market Opportunity
DUBLIN, April 10, 2018 /PRNewswire/ — The “Interventional Cardiology and Peripheral Vascular Device Market Report: Trends, Forecast and Competitive Analysis”report has been added to ResearchAndMarkets.com’s offering. The global interventional cardiology and peripheral vascular device market is expected to reach an estimated $26.3 billion by 2023, and it is forecast to grow at a CAGR of 5.5% from […]



